OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Macromolecular Modelling and Docking Simulations for the Discovery of Selective GPER Ligands
Camillo Rosano, Marco Ponassi, Maria Francesca Santolla, et al.
The AAPS Journal (2015) Vol. 18, Iss. 1, pp. 41-46
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Estrogenic control of mitochondrial function
Carolyn M. Klinge
Redox Biology (2020) Vol. 31, pp. 101435-101435
Open Access | Times Cited: 194

G Protein–Coupled Estrogen Receptor GPER: Molecular Pharmacology and Therapeutic Applications
Jeffrey B. Arterburn, Eric R. Prossnitz
The Annual Review of Pharmacology and Toxicology (2023) Vol. 63, Iss. 1, pp. 295-320
Open Access | Times Cited: 56

A role for G-protein coupled estrogen receptor (GPER) in estrogen-induced carcinogenesis: Dysregulated glandular homeostasis, survival and metastasis
Edward J. Filardo
The Journal of Steroid Biochemistry and Molecular Biology (2017) Vol. 176, pp. 38-48
Closed Access | Times Cited: 51

Continuous Evaluation of Ligand Protein Predictions: A Weekly Community Challenge for Drug Docking
Jeffrey Wagner, Christopher Churas, Shuai Liu, et al.
Structure (2019) Vol. 27, Iss. 8, pp. 1326-1335.e4
Open Access | Times Cited: 47

GPCR Modulation in Breast Cancer
Rosamaria Lappano, Yves Jacquot, Marcello Maggiolini
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 12, pp. 3840-3840
Open Access | Times Cited: 46

Exploring the anticancer and antioxidant properties of Vicia faba L. pods extracts, a promising source of nutraceuticals
Jessica Ceramella, Chiara La Torre, Michele De Luca, et al.
PeerJ (2022) Vol. 10, pp. e13683-e13683
Open Access | Times Cited: 20

GPER as a Receptor for Endocrine-Disrupting Chemicals (EDCs)
Séverine Perian, Jean-Marc Vanacker
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 28

Effects of Bisphenols on RACK1 Expression and Their Immunological Implications in THP-1 Cells
Erica Buoso, Maša Kenda, Mirco Masi, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 24

N‐Heterocyclic Carbene (NHC) Silver Complexes as Versatile Chemotherapeutic Agents Targeting Human Topoisomerases and Actin
Annaluisa Mariconda, Domenico Iacopetta, Marco Sirignano, et al.
ChemMedChem (2022) Vol. 17, Iss. 18
Open Access | Times Cited: 18

The Role of Estrogen and Estrogen Receptors in Head and Neck Tumors
Jacqueline-Katrin Kranjčević, Josipa Čonkaš, Petar Ozretić
Cancers (2024) Vol. 16, Iss. 8, pp. 1575-1575
Open Access | Times Cited: 3

Design, synthesis and biological evaluation of multitarget hybrid molecules containing NHC-Au(I) complexes and carbazole moieties
Alfonsina D’Amato, Domenico Iacopetta, Jessica Ceramella, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116757-116757
Closed Access | Times Cited: 3

Tissue-specific transcriptome analyses provide new insights into GPCR signalling in adult Schistosoma mansoni
Steffen Hahnel, Nic Wheeler, Zhigang Lu, et al.
PLoS Pathogens (2018) Vol. 14, Iss. 1, pp. e1006718-e1006718
Open Access | Times Cited: 31

Calixpyrroles: from Anion Ligands to Potential Anticancer Drugs
Franz H. Kohnke
European Journal of Organic Chemistry (2020) Vol. 2020, Iss. 28, pp. 4261-4272
Closed Access | Times Cited: 24

Computational Approaches for the Discovery of GPER Targeting Compounds
Fedora Grande, Maria Antonietta Occhiuzzi, Rosamaria Lappano, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 24

Effects of endocrine active contaminating pesticides on RACK1 expression and immunological consequences in THP-1 cells
Ambra Maddalon, Mirco Masi, Martina Iulini, et al.
Environmental Toxicology and Pharmacology (2022) Vol. 95, pp. 103971-103971
Closed Access | Times Cited: 15

The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells
Rosamaria Lappano, Christophe Mallet, Bruno Rizzuti, et al.
Cells (2019) Vol. 8, Iss. 6, pp. 590-590
Open Access | Times Cited: 25

GPER binding site detection and description: A flavonoid-based docking and molecular dynamics simulations study.
David Méndez-Luna, Sonia Guzmán‐Velázquez, Itzia-Irene Padilla-Martínez, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2024) Vol. 239, pp. 106474-106474
Closed Access | Times Cited: 2

A novel GPER antagonist protects against the formation of estrogen-induced cholesterol gallstones in female mice
Chelsea DeLeon, Helen H. Wang, Joseph Gunn, et al.
Journal of Lipid Research (2020) Vol. 61, Iss. 5, pp. 767-777
Open Access | Times Cited: 18

Molecular insights into the effects of tetrachlorobisphenol A on puberty initiation in Wistar rats
Bingli Lei, Yingxin Yang, Lanbing Xu, et al.
The Science of The Total Environment (2023) Vol. 911, pp. 168643-168643
Closed Access | Times Cited: 6

Non-genomic oestrogen receptor signal in B lymphocytes: An approach towards therapeutic interventions for infection, autoimmunity and cancer
Karsen Seto, Minh Hoang, T.Quirico Santos, et al.
The International Journal of Biochemistry & Cell Biology (2016) Vol. 76, pp. 115-118
Closed Access | Times Cited: 13

Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPER
Oscar Zacarías-Lara, David Méndez-Luna, Gustavo Ulises Martinez‐Ruíz, et al.
Anti-Cancer Agents in Medicinal Chemistry (2018) Vol. 19, Iss. 6, pp. 760-771
Closed Access | Times Cited: 13

Modifications on the Tetrahydroquinoline Scaffold Targeting a Phenylalanine Cluster on GPER as Antiproliferative Compounds against Renal, Liver and Pancreatic Cancer Cells
David Méndez-Luna, Loreley Araceli Morelos-Garnica, J. Benjamín García‐Vázquez, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 1, pp. 49-49
Open Access | Times Cited: 11

Multiplex G Protein–Coupled Receptor Screen Reveals Reliably Acting Agonists and a Gq-Phospholipase C Coupling Mode of GPR30/GPER1
Nicole Urban, Marion Leonhardt, Michael Schaefer
Molecular Pharmacology (2022) Vol. 103, Iss. 2, pp. 48-62
Open Access | Times Cited: 8

The Antitumor Peptide ERα17p Exerts Anti-Hyperalgesic and Anti-Inflammatory Actions Through GPER in Mice
Christophe Mallet, Ludivine Boudieu, Sylvain Lamoine, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 10

Page 1 - Next Page

Scroll to top